News | News By Subject | News by Disease News By Date | Search News

Contraception, female News Articles

Get Our FREE
Industry eNewsletter
Top Breaking News
3 Biotechs Expecting to Release Clinical Trial Data Soon     9/1/2016
Federal Judge Rules Against Nearly 1,300 Lawsuits Over Bayer (BAY)'s IUD Mirena     7/29/2016
Pfizer (PFE) Debuts First Self-Injectable Contraceptive in UK     9/24/2015
AmerisourceBergen Corporation (ABC) the “Pony to Ride” for Biosimilar Opportunities, Says UBS     3/16/2015
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data     12/3/2014
European Medicines Agency Recommends Availability Of Laboratoire HRA Pharma's Ellaone Emergency Contraceptive Without Prescription     11/21/2014
Best Value In Biotech? Actavis (ACT), Says UBS     11/17/2014
Glenmark Pharmaceuticals in Talks to Sell Its Oral Contraceptive Unit     10/4/2013
Warner Chilcott, PLC (WCRX) Announces FDA Approval of New Oral Contraceptive     7/25/2013
Teva Pharmaceutical Industries Limited (TEVA) Gets Exclusivity on Plan B Contraceptive     7/24/2013
FDA Approves Teva Pharmaceutical Industries Limited (TEVA) Drug as First OTC Morning After Pill, Lifts Age Limit     6/21/2013
Johnson & Johnson (JNJ) Recalls 32 Million Boxes of Contraceptives From 43 Countries     6/5/2013
Warner Chilcott, PLC (WCRX) Announces FDA Approval of New Oral Contraceptive     4/23/2013
Bayer AG (BAYN.DE) Patent on Yaz Birth Control Pill Ruled Invalid     4/18/2013
Teva Pharmaceutical Industries Limited (TEVA) Wins FDA Approval for Oral Contraceptive     4/2/2013

News from Around the Web
Morning-After Pill To Be Made Available Without Prescription     12/14/2016
President-Elect Trump Could Deprive Women Of Reproductive Rights — Here's How Some Women Are Responding     11/10/2016
New 5-Year Contraceptive Coming To U.S. Adds To Long-Acting Reversible Contraceptives List     9/21/2016
What Really Happens When Women Stop Taking Birth Control, National Institute of Environmental Health Sciences Study     8/5/2016
Could The Most Effective Birth Control Soon Become The Cheapest?     5/3/2016
Birth Control Pills May Increase Risk Of Seizures, Texas A&M University Study     3/31/2016
More Women Opt For IUD, Contraceptive Implant For Birth Control, Guttmacher Institute Reveals     11/10/2015
As Apple (AAPL), Facebook Offer Egg Freezing, Debate Swirls     10/20/2014
Woman Hospitalized After "Potato Contraceptive" Grows Roots In Vagina     10/6/2014
Birth Control Pills May Double Breast Cancer Risk, Fred Hutchinson Cancer Research Center Study     8/4/2014
Does The Pill Change What Women Want In A Mate? University of Florence Study     6/9/2014
Obama Administration Keeps Limit on Teva Pharmaceutical Industries Limited (TEVA) Morning-After Pill, Marks First Time US Overrules FDA     12/9/2011
Newer Oral Contraceptive as Safe for Gall Bladder as Older Birth-Control Pills, University of British Columbia Study Suggests     4/26/2011
Birth Control Pills: Some Carry Higher Risk of Blood Clots, Northwestern University Study     4/22/2011
Gallbladder Risk no Higher With Newer "Pill" - University of British Columbia and Collaborators Study Finds     4/20/2011

Press Releases
Medicines360 And Allergan (AGN) Present Four-Year Multi-Center Pivotal Trial Data Of LILETTA (Levonorgestrel-Releasing Intrauterine System) 52 Mg At The 2017 American College of Obstetricians and Gynecologist Meeting     5/9/2017
Agile Therapeutics, Inc. Announces Results Of Its Pre-Submission Meeting With FDA     4/11/2017
Bayer (BAY)'s Canadian Contraception Family Is Growing With The Launch Of Kyleena     3/20/2017
Mithra Pharmaceuticals Release: Company Announces Us Patent Allowance For The Use Of Estetrol As Emergency Contraceptive     1/18/2017
Agile Therapeutics, Inc. Announces Positive Top-line Phase III Results     1/4/2017
Agile Therapeutics, Inc. Reports Third Quarter 2016 Financial Results And Announces Completion Of Subject Visits For Twirla Phase III SECURE Clinical Trial     11/8/2016
Medicines360 And Allergan (AGN) Announce Publication Of Levonorgestrel Release Rates Over Five Years With The LILETTA 52 Mg Intrauterine System In 'Contraception'     9/7/2016
Juniper Pharma (JNP) Expands Lead Phase 2b Trial, Submits Pre-IND Meeting Request For Its First Intra-Vaginal Ring Product, And Adds Four Key Executives     1/11/2016
Lupin (LUPN.BO) Launches Generic Ortho Tri-Cyclen Lo Tablets In The US     1/6/2016
Agile Therapeutics, Inc. Announces Completion Of Patient Enrollment In Twirla Phase 3 SECURE Clinical Trial     10/19/2015
Women Ask the FDA to Withdraw Bayer (BAY)'s Controversial Contraceptive Essure     9/25/2015
Complaints for Bayer AG (BAYZF)'s Sterility Device Spike Nearly 1,400% in Three Years     9/22/2015
Allergan (AGN) Partners With U.S. Women's Health Alliance Increasing Access To LILETTA (Levonorgestrel-Releasing Intrauterine System) 52 Mg     9/16/2015
Agile Therapeutics, Inc. Announces Completion Of Patient Recruitment In Twirla Phase III SECURE Clinical Trial     9/1/2015
The Female Health Company Receives Orders For 15 Million FC2 From Brazil     8/31/2015